Skip to main content

Guttmacher Institute

Donate Now

Highlights

  • Roe v. Wade in Peril
  • COVID-19 impact
  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics
  • Public-use data sets

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health
  • Perspectives on Sexual and Reproductive Health

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship

Search form

Good reproductive health policy starts with credible research

 

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email
Guttmacher Institute

Good reproductive health policy starts with credible research

 

Donate Now

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email

Highlights

  • Roe v. Wade in Peril
  • COVID-19 impact
  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics
  • Public-use data sets

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health
  • Perspectives on Sexual and Reproductive Health

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship

Search form

United States

Contraception

When women and their partners have access to a wide range of contraceptive methods, they are better able to plan and space their births. This leads to positive health, social and economic outcomes for women, families and society. The Guttmacher Institute documents the need for, access to and use of contraceptives and provides the evidence base for public investment in high-quality and affordable family planning services that provide a full range of methods, comprehensive and accurate information, and effective counseling.

  • Affordable Care Act (ACA)
  • Publicly Funded Family Planning
  • State Policies on Contraception
  • Reproductive Health Impact Study

  • Fact Sheet

    Contraceptive Use in the United States by Demographics

  • Policy Analysis

    What Federal Policymakers Must Do to Restore and Strengthen a Title X Family Planning Program That Serves All

Top Facts & Statistics

  • 99%

    of sexually active American women 15–44 have used a contraceptive method other than natural family planning
  • 30

    years the average U.S. woman uses contraceptives to attain her family planning goal of two children
  • 2-12%

    increase in contraceptive users who relied on a long-acting reversible contraceptive (LARC) method between 2002 and 2012

Resources

  • May 2008 Report

    Improving Contraceptive Use in the United States

    United States

    • Contraception
  • January 2007 Research Article

    Explaining Recent Declines in Adolescent Pregnancy in the United States: The Contribution of Abstinence and Improved Contraceptive Use

    John S. Santelli, Susheela Singh, Laura D. Lindberg and Lawrence B. Finer,American Journal of Public Health

    United States

    • Contraception
    • Pregnancy
    • Teens
  • June 2004 Report

    Contraceptive Needs and Services, 2001-2002

    United States

    • Contraception
  • May 2004 Policy Analysis

    Family planning waivers work, research shows

    Rachel Benson Gold,Contraceptive Technology Update

    United States

    • Contraception
  • April 2002 Report

    Family Planning Can Reduce High Infant Mortality Levels

    United States

    • Contraception
  • March 2002 Policy Analysis

    Overhauling welfare: implications for reproductive health policy in the United States.

    Heather D. Boonstra and Rachel Benson Gold,Journal of the American Medical Women’s Association

    United States

    • Contraception
  • January 2000 Policy Analysis

    The “boom and bust phenomenon”: the hopes, dreams, and broken promises of the contraceptive revolution

    Heather D. Boonstra,Contraception

    United States

    • Contraception

Pages

  • « first
  • ‹ previous
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
Explore the Data Center

Hear From An Expert

We’re just beginning to discover the extent to which women use hormonal contraceptives for purposes other than pregnancy prevention. One example is oral contraceptive pills—about 14% of pill users take them solely for noncontraceptive purposes, including menstrual pain relief.

Rachel K. Jones

Principal Research Scientist

Select a state

View State Policy Updates
Guttmacher Institute
Reproductive rights are under attack. Will you help us fight back with facts?
Donate Now
Follow Guttmacher:

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Footer Menu

  • Privacy Policy
© 2022 Guttmacher Institute. The Guttmacher Institute is registered as a 501(c)(3) nonprofit organization under the tax identification number 13-2890727. Contributions are tax deductible to the fullest extent allowable.

Get Our Updates